Paeds Cases · mental-behavioural-and-psychosomatic
Explain disruptive mood dysregulation disorder to parents — OSCE
OSCE communication and shared-planning station: explaining a criteria-based diagnosis of DMDD, ruling out bipolar, the behaviour-therapy-first plan with parent training and child CBT, when a drug is justified for comorbidity, and why an antipsychotic is not the routine first step.
On this page
Study tools
Target exams
Candidate instructions
You are the paediatric registrar. The parents of an eight-year-old boy with severe temper outbursts three to four times a week and a chronically irritable mood at home and school for over a year have ten minutes with you. They have read online that he might be bipolar and want medication to calm him down. Explain, in plain language: (1) what disruptive mood dysregulation disorder is and why it is a treatable mood-dysregulation condition; (2) why this is not bipolar disorder and how you excluded it; (3) how parent training and emotion-regulation therapy work and why they come first; and (4) when a medicine is genuinely justified and why a sedating drug is not the routine first step. Invite their questions and agree a shared plan. Do not lecture; check understanding throughout. [1]
References4ShowHide
- [1]Copeland WE, Costello EJ, Angold A, et al. Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder. Am J Psychiatry, 2013.PMID 23377638
- [2]Breaux R, Baweja R, Eadeh HM, et al. Systematic review and meta-analysis: pharmacological and nonpharmacological interventions for persistent nonepisodic irritability. J Am Acad Child Adolesc Psychiatry, 2023.PMID 35714838
- [3]Waxmonsky JG, Waschbusch DA, Belin P, et al. A randomized clinical trial of an integrative group therapy for children with severe mood dysregulation. J Am Acad Child Adolesc Psychiatry, 2016.PMID 26903253
- [4]Baweja R, Belin PJ, Humphrey HH, et al. The effectiveness and tolerability of central nervous system stimulants in school-age children with attention-deficit/hyperactivity disorder and disruptive mood dysregulation disorder. J Child Adolesc Psychopharmacol, 2016.PMID 26771437